行气利水散敷脐治疗癌性腹水的临床观察  

Clinical observation of “Xingqi Lishui Powder”on external treatment of malignant ascites

作　　者：顾芳红[1] 周建伟[1] 张翔[1] 

机构地区：[1]复旦大学附属中山医院青浦分院中医科,上海201700

出　　处：《上海中医药杂志》2016年第5期39-41,共3页Shanghai Journal of Traditional Chinese Medicine

基　　金：复旦大学附属中山医院青浦分院院级课题(QY2013-02)

摘　　要：目的观察行气利水散敷脐治疗癌性腹水的临床疗效。方法将60例癌性腹水患者随机分为治疗组和对照组,每组30例。对照组予氨体舒通和速尿,治疗组在对照组治疗措施基础上加用行气利水散敷脐。两组疗程均为10天,观察临床疗效,比较中医证候积分、腹部胀痛评分的变化情况。结果 1治疗组、对照组临床总有效率分别为73.33%和13.33%;组间临床疗效比较,差异有统计学意义,即治疗组明显优于对照组(P<0.05)。2治疗前后组内比较,两组中医证候积分与腹部胀痛评分差异均有统计学意义(P<0.05);组间治疗后比较,中医证候积分与腹部胀痛评分差异有统计学意义(P<0.05)。结论行气利水散敷脐治疗癌性腹水的疗效满意,可明显减少腹水,缓解临床症状。Objective To observe the clinical effects of ＂Xingqii Lishui Powder＂ on topical treatment of malignant ascites. Methods Sixty subjects were randomly divided into treatment group and control group, 30 cases in each group. The control group was treated with spironolactone and furosemide tablet, and the treatment group was treated by ＂Xingqi Lishui Powder＂ on navel compression besides the treatment in the control group, with a course 10 days. The TCM symptom score and abdominal pain score were observed before and after treatment. Results （~）The effective rates of treatment group and control group were 73.33% and 13.33% respectively, with better effects in the treatment group than in the control group （P 〈 0.05 ）. （~）There were striking differences in TCM syndrome score and abdominal pain score between before and after treatment in both groups（ P 〈0.05 ） ; after treatment, there was a significant difference between treatment group and control group（P 〈0.05 ）. Conclusion ＂Xingqi Lishui Powder＂ on navel compression in effective to treat cancerous ascites in relieving ascites and improving the quality of life.

关 键 词：癌性腹水 行气利水散 脐疗 内病外治 

分 类 号：R273[医药卫生—中西医结合]